Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioNeutra Global's Operating Income for the
three
months ended in Sep. 2024 was $-0.21 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.24 Mil.
Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
BioNeutra Global's annualizedROC % for the quarter that ended in Sep. 2024 was -12.16%.
BioNeutra Global's annualizedROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -10.53%.
BioNeutra Global (OTCPK:BGACF) Operating Income Explanation
1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
BioNeutra Global's annualizedROC % for the quarter that ended in Sep. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.
Be Aware
Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
BioNeutra Global Operating Income Related Terms
BioNeutra Global Operating Income Historical Data
* Premium members only.
The historical data trend for BioNeutra Global's Operating Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.
Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioNeutra Global (BGACF) has a Operating Income of $-0.24 Mil as of Sep. 2024. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on BioNeutra Global and its competitors.
Is BioNeutra Global's Operating Income too high?
BioNeutra Global's current Operating Income is $-0.24 Mil.
How does BioNeutra Global's Operating Income compare to ARRT and BSFC?
BioNeutra Global's Operating Income of $-0.24 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Consumer Packaged Goods company?
A good Operating Income depends on the Consumer Packaged Goods industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on BioNeutra Global and its competitors. BioNeutra Global's current Operating Income is $-0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNeutra Global stock overvalued right now?
BioNeutra Global (BGACF) has a current Operating Income of $-0.24 Mil. The current Operating Income is $-0.24 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For BioNeutra Global (BGACF), the current Operating Income is $-0.24 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGACF has been successfully added to your 
